Bill > HB18

This bill authorizes the importation of prescription drugs into Mississippi under specific conditions, creating a legal framework for drug importation that aims to potentially reduce prescription drug costs. The bill defines key terms like "distributor," "wholesaler," and "pharmacy" by referencing existing state law, and establishes clear guidelines for who can import and export prescription drugs. Eligible exporters include international prescription drug wholesale distributors, nonresident prescription drug manufacturers, and international export pharmacies, while eligible importers are wholesale distributors, pharmacies, and pharmacists. To be legally imported, a prescription drug must meet United States Food and Drug Administration (FDA) standards for safety, effectiveness, and labeling, and must not violate any U.S. patent laws. The legislation provides a structured approach to allowing prescription drug importation, potentially offering Mississippi consumers more options for accessing medications, with the law set to take effect on July 1, 2025. By creating this importation pathway, the bill seeks to provide safe and potentially more affordable prescription drug options for the state's residents.

Health and Social Services

https://billstatus.ls.state.ms.us/2025/pdf/history/HB/HB0018.xml